Protein-Serine-Threonine Kinases

DBCAT004626Pharmacologic class

A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. A DrugBank category of 2 drugs. 1 of them is approved.

Drugs: Dalantercept
Luspatercept

What you can answer from here — as of May 21, 2019

2DrugsEach linked to its full drug card

Listed above

4Drug targetsEvery drug–target pair in the class, with bond type

11Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Protein-Serine-Threonine Kinases share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account